Open AccessEffectiveness of Lifestyle Intervention in the Management of Type 2 Diabetes
Author(s) -
Martin Ifeanyi Okeke,
Musa Ahemed Abdullah
Publication year - 2020
Publication title -
international journal of advanced research
Language(s) - English
Resource type - Journals
eISSN - 2707-7810
pISSN - 2707-7802
DOI - 10.37284/ijar.2.1.115
Subject(s) - type 2 diabetes , medicine , intervention (counseling) , randomized controlled trial , gerontology , insulin resistance , disease , population , diabetes mellitus , obesity , pandemic , disease management , critical appraisal , alternative medicine , environmental health , nursing , covid-19 , endocrinology , pathology , parkinson's disease , infectious disease (medical specialty)
Prevention is believed to be a centrepiece to the effective management of people’s health and improvement of their wellbeing. However, a critical question often asked is how an individual can coherently address the underlying causes of diseases ensuring they live a healthy life. In the midst of this thought and pursuit, diabetes remains one of the common diseases with over 415 million across the globe estimated to be living with the condition of whom over 193 million are believed to be undiagnosed. T2D is resultant of relative insulin deficiency that is caused by the dysfunction of pancreatic β-cell and resistance of insulin in the target organs. T2D has become a global pandemic and a chronic disease characterized by high mortality and late complications; it was the sixth leading cause of mortality in 2015. The increasing T2D prevalence is attributed to the global rise in the rate of sedentary lifestyles, obesity, and ageing population. Several studies have assessed the implication and effectiveness of lifestyle intervention in the prevention and management of T2D. Therefore, this study being an evidence-based research, appraised published studies from 2017 to 2019 on the effectiveness of lifestyle intervention in the management of Type 2 Diabetes using a Critical Appraisal Skills Program (CASP) for randomized controlled trials (RCT).